BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 28, 2016
View Archived Issues
Janssen, BMS enter immuno-oncology collaboration in lung cancer
Read More
First pivotal trial of intravenous meloxicam achieves primary endpoint
Read More
Eisai doses first patient in phase Ib/II study of Halaven plus Halozyme's PEGPH20
Read More
Sysmex, Healios and Sumitomo Dainippon partner to develop pre-transplant immune reaction testing
Read More
Hisamitsu reports results from phase III study of HP-3060 transdermal system for allergic rhinitis
Read More
Pneumococcal vaccination using novel hybrid biological-biomaterial vector
Read More
X-Chem and AbbVie form oncology and immunology drug target collaboration
Read More
First-in-human trial investigates AGuIX gadolinium-based nanoparticles in brain metastases
Read More
Burnet Institute and ARTES Biotechnology to jointly develop HCV vaccine
Read More
Neurovance's phase II study of centanafadine in adult ADHD meets endpoints
Read More
Beijing Scitech-Mq Pharmaceuticals patents HER1 inhibitors
Read More
Phase I study of FluGen's universal influenza vaccine begins
Read More
EMA grants PRIME designation to DNX-2401 for recurrent glioblastoma
Read More
DPP Zika IgM/IgG assay obtains CE mark for rapid point-of-care detection of Zika virus
Read More
Shanghai Institute Materia Medica discloses glucokinase activators
Read More
HHS and Yale University develop c-Myc inhibitors
Read More
First phase I data for PF-06648671
Read More
FDA approves Adlyxin for type 2 diabetes
Read More
FTC clears Teva's acquisition of Actavis Generics
Read More
Kite Pharma enters license agreement with NIH for fully human anti-CD19 CAR-based product candidate
Read More
Pfizer wins auction bid for substantially all of BIND Therapeutics' assets
Read More
FDA accepts for review BioMarin's BLA for cerliponase alfa for CLN2 disease
Read More
First clinical data for 5-HT-4 receptor partial agonist SUVN-D4010
Read More
Cytokinetics and Astellas expand collaboration in skeletal muscle activators
Read More
Preclinical profile of novel dual inhibitors of Abeta and tau oligomerization
Read More
GSK licenses CNTO-7160 for severe asthma from Janssen
Read More
AstraZeneca and Moderna Therapeutics apply to start clinical study of AZD-860 in Germany
Read More